Table 2

Incidence rates and HRs of obstructive sleep apnoea in study population by study cohort and covariates

VariableEventPYRate†Relative HR (95% CI)Adjusted HR‡ (95% CI)
RA
 No39225 1651.731.001.00
 Yes67220 5363.041.75 (1.18 to 2.60)***1.75 (1.18 to 2.60)***
Age, year
 20–4942186 8572.251.001.99 (1.09 to 3.65)*
 50–6444170 3492.581.15 (0.75 to 1.75)1.64 (0.95 to 2.83)
 ≥652088 4932.261.00 (0.59 to 1.71)1.00
Sex
 Female53353 4961.501.001.00
 Male5392 2055.753.84 (2.62 to 5.62)***4.19 (2.85 to 6.15)***
Comorbidity
Hypertension
 No63314 1592.011.001.00
 Yes43131 5423.271.63 (1.11 to 2.41)*1.12 (0.69 to 1.80)
Diabetes
 No95414 7082.291.001.00
 Yes1130 9933.551.55 (0.83 to 2.90)
Hyperlipidaemia
 No70364 8481.921.001.00
 Yes3680 8534.452.33 (1.56 to 3.48)***1.88 (1.19 to 2.96)**
IHD
 No74383 5691.931.001.00
 Yes3262 1315.152.68 (1.77 to 4.07)***2.41 (1.47 to 3.95)***
Dysrhythmia
 No96420 5242.281.001.00
 Yes1025 1763.971.74 (0.91 to 3.35)
CHF
 No102436 2632.341.001.00
 Yes494384.241.81 (0.67 to 4.93)
Stroke
 No103435 9552.361.001.00
 Yes397463.081.30 (0.41 to 4.11)
CKD
 No103440 3922.341.001.00
 Yes353095.652.41 (0.76 to 7.59)
Asthma/COPD
 No92408 4102.251.001.00
 Yes1437 2913.751.67 (0.95 to 2.94)
Obesity
 No100441 1552.271.001.00
 Yes6454613.25.86 (2.57 to 13.4)***5.22 (2.24 to 12.2)***
  • *p<0.05, ** p<0.01, *** p<0.001.

  • †Incidence rate per 10 000 person-years.

  • ‡Multivariable analysis including sex, age and comorbidities of hypertension, diabetes, hyperlipidemia, IHD, dysrhythmia, CHF, stroke, CKD, asthma/COPD and obesity.

  • CHF, congestive heart failure; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; IHD, ischemic heart disease; PY, person-years; RA, rheumatoid arthritis.